Eurazeo NAV per share hits record high

The GP said its assets under management grew by 39% over the 12 months to June 2021, to reach €25.6bn. Gross value creation of the portfolio totalled EUR 1,240m, up by 22% during H1 2021.

The firm's deployment totalled EUR 2.7bn over H1, with realisations amounting to EUR 1.3bn.

Eurazeo has enjoyed a busy streak of exits in recent months, with the GP selling its stakes in Intech, Grandir, Iberchem, Trader Interactive and Planet this year. The firm has also launched the sale of Peters Surgical, as reported. Eurazeo plans to accelerate its asset divestment programme in 2021 and 2022 given the maturity of its PE portfolio, as reported by Unquote.

Eurazeo saw record fundraising in H1 at EUR 2.4bn, with several funds closing their fundraising above their initial targets.

The firm held a final close for its third growth fund on EUR 1.6bn, surpassing its EUR 1bn target. The GP also raised EUR 1bn for its secondaries programme in July 2021, as reported. Most recently, it announced a final close for Idinvest Private Debt V on EUR 1.5bn, exceeding its EUR 1.2bn target.

In addition, Eurazeo launched Eurazeo PME IV in May 2021, as reported; the fund focuses on mid-market businesses with enterprise values of EUR 50m-500m. The GP said the fund has already secured more than EUR 700m (including EUR 400m from Eurazeo's balance sheet) based on a target of around EUR 1bn.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• GPs
• Performance
• France
• Eurazeo
• France